Radiology is the part of Indian healthcare where AI has had the deepest measured impact. By 2026, the Indian market has matured past the demo-vs-production debate — AI now sits inside live diagnostic workflows at hundreds of hospitals across Tier 1, Tier 2, and Tier 3 cities. This guide explains the regulatory frame, the vendor landscape, the practical use-cases, and what hospital procurement teams should ask before signing.
5C Network operates one of the largest deployed radiology AI platforms in India — Bionic Vision (computer vision), Bionic Voice (voice-to-report), and Bionic LM (quality control) — running inside the same workflow as 400+ board-certified radiologists. The view here is platform-and-services, but the vendor landscape section names the major point-solution players objectively.
The Indian regulatory framework: CDSCO, MDR 2017, DPDP Act
AI used for diagnostic interpretation is software-as-a-medical-device (SaMD). In India, this is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Medical Device Rules, 2017, with explicit SaMD provisions introduced in the 2023 amendment. Most radiology AI products are Class B or Class C devices. Import or sale in India requires CDSCO registration via an Indian licence holder, plus an ISO 13485 quality management system from the manufacturer.
For hospitals, this means: before purchasing radiology AI, verify the vendor's CDSCO registration number and the device class. Marketing material is not regulatory clearance. Cloud-deployed AI also needs to meet the Digital Personal Data Protection Act, 2023 (DPDP Act) — patient consent, data localisation, and breach notification all apply. International ISO certifications (ISO 27001, ISO 27701, HIPAA) are now table stakes for any platform serving Indian hospitals.
The vendor landscape in 2026
The Indian radiology AI market splits cleanly into two architectures.
Point-solution AI: vendors that solve one pathology or one modality. Qure.ai is the most-recognised Indian-origin player, with strong chest X-ray TB and stroke triage products deployed across public-health programmes. DeepTek and SigTuple are also active in this segment. Global point-solutions with India presence include Aidoc, Annalise.ai, Rad AI, and Nanox.AI. Each typically requires its own integration, separate licensing, and a separate viewer.
Platform AI plus services: an end-to-end layer that covers multiple modalities, integrates AI into a single radiologist-facing workflow, and ships with the radiologist services to actually deliver reports. This is the model 5C Network runs. Other variants include OEM-bundled offerings from GE Edison and Siemens AI-Rad Companion, which are typically tied to scanner hardware.
Hospital procurement teams are increasingly choosing the platform-and-services route — one contract, one integration, accountable for the entire diagnostic outcome — rather than stitching together five point-solutions.
The four use-cases that actually matter
Most radiology AI marketing makes the technology sound like it does everything. In practice, four use-cases drive real value in an Indian hospital workflow:
- Triage and prioritisation. AI scans the worklist and pushes the highest-acuity studies — intracranial bleed, large-vessel occlusion, tension pneumothorax, free air — to the top of the radiologist's queue. This is where AI most directly moves clinical outcomes.
- Pre-read pathology detection. Before a radiologist opens a study, AI marks suspected findings on the image — TB lesions on a chest X-ray, lung nodules on a CT, fractures on a trauma X-ray. Bionic Vision flags hundreds of pathologies across modalities with an average F1 score of 0.93.
- Quantification. AI handles the busywork — counting and measuring lung nodules, calculating Cobb angle on scoliosis films, volumetric analysis on stroke CTs. This is where radiologist productivity gains compound.
- Concurrent QC. Before a report is signed, an AI quality layer checks for contradictions, missing template sections, and unanswered clinical questions. Bionic LM runs 8 specialised QC agents and reduces rejection rates by 40%.
What to ask before buying radiology AI in India
- Show me the CDSCO registration number and device class. Not the FDA, not the CE mark. CDSCO for India.
- What fraction of training data is Indian? Indian chest X-rays, Indian CTs. Models trained on US-only data underperform on Indian populations.
- Where does the inference run? Cloud (lower TCO, faster deployment) or on-premise GPU (higher capital cost, slower upgrades).
- What is the integration timeline? Cloud-native should be live in under 72 hours. Anything longer means rip-and-replace IT work.
- Is the radiologist read included or sold separately? AI without a radiologist is research, not a reporting workflow.
- What is the support model for false negatives? Every AI vendor should have published performance metrics and a clinical accountability process.
Frequently asked questions
Is radiology AI regulated in India?
Yes. AI-based software intended for diagnostic use is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Medical Device Rules, 2017, which classify software-as-a-medical-device (SaMD). Most radiology AI products are Class B or Class C devices and require CDSCO registration via an Indian licence holder. The 2023 update to the Medical Device Rules added explicit SaMD provisions. Patient data handling falls under the Digital Personal Data Protection Act, 2023 (DPDP Act).
Which radiology AI vendors operate in India?
The India radiology AI market includes domestic players — 5C Network (AI platform plus radiology services), Qure.ai (chest X-ray and stroke triage), DeepTek, SigTuple — and global vendors with India presence — Aidoc, Annalise.ai, Rad AI, Nanox.AI, GE Edison, Siemens AI-Rad Companion. The market splits into two models: point-solution AI (one vendor per pathology) and platform AI (a single layer that covers multiple modalities and ships with radiologist services). Most Indian hospitals are converging on the platform model.
What does radiology AI actually do in a hospital workflow?
Useful radiology AI delivers four things: (1) triage — flagging the highest-priority studies for radiologist review first, (2) detection — highlighting suspected pathologies on the image before the radiologist opens it, (3) measurement — automating volumetrics, nodule sizing, and Cobb angle, (4) quality control — running concurrent checks on the final report before sign-off. AI does not replace the radiologist; a board-certified radiologist signs every report. AI removes the busywork and surfaces the cases that need attention.
Does an Indian hospital need to install hardware to run radiology AI?
No, if you choose a cloud-native platform. 5C's AI runs entirely in the cloud — the hospital just routes DICOM images via a secure connection, and reports come back through the same channel. Most Indian deployments go live in under 72 hours with zero on-premise hardware. On-premise GPU appliances are still sold by some vendors but are increasingly hard to justify.
How accurate is radiology AI for Indian patient populations?
Accuracy depends on training data. Models trained primarily on US or European populations underperform on Indian chest X-rays — TB prevalence, body habitus, and imaging protocols differ. Bionic Vision, 5C's computer vision engine, is trained on 3+ billion medical images from Indian hospitals and achieves an average F1 score of 0.93 across hundreds of pathologies. Ask any vendor what fraction of their training set is Indian — the answer matters more than the headline accuracy number.
See 5C's radiology AI platform
Bionic Vision, Voice, and LM — trained on 3+ billion Indian medical images, deployed at 1,500+ hospitals, signed by 400+ radiologists.
